Panel recommends Serum Institute's name for phase 2, 3 human clinical trials of Oxford vaccine candidate

The recommendations of the committee at the Central Drugs Standard
Control Organisation have been sent to the Drugs Controller General of
India for approval.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/panel-recommends-serum-institutes-name-for-phase-2-3-human-clinical-trials-of-oxford-vaccine-candidate/articleshow/77287839.cms

Comments

Popular posts from this blog

NISER PhD Program Admission 2020-21 (Winter Session)

Data Analyst Jobs – Life Sciences Apply at Cognizant

NIMHANS Virology & Life Sciences Research Officer Recruitment